Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM)
USD 26.35
(1.35%)
USD 26.35
(1.35%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 109.08 Million USD | 629.48% |
| 2022 | 15.95 Million USD | -55.41% |
| 2021 | 35.78 Million USD | 86.09% |
| 2020 | 19.23 Million USD | 19.89% |
| 2019 | 16.04 Million USD | 90.75% |
| 2018 | 8.41 Million USD | -24.28% |
| 2017 | 11.1 Million USD | 139.74% |
| 2016 | 4.63 Million USD | -18.33% |
| 2015 | 5.67 Million USD | 169.25% |
| 2014 | -8.19 Million USD | 47.42% |
| 2013 | -15.57 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 123.12 Million USD | 5.76% |
| 2024 Q2 | 114.05 Million USD | -1.43% |
| 2023 Q2 | 154.66 Million USD | -1.79% |
| 2023 Q1 | 157.48 Million USD | 886.8% |
| 2023 Q4 | 116.41 Million USD | -6.19% |
| 2023 Q3 | 124.09 Million USD | -19.76% |
| 2023 FY | 116.41 Million USD | 629.48% |
| 2022 Q2 | 33.94 Million USD | -8.72% |
| 2022 Q4 | 15.95 Million USD | -55.05% |
| 2022 FY | 15.95 Million USD | -55.41% |
| 2022 Q1 | 37.18 Million USD | 3.89% |
| 2022 Q3 | 35.5 Million USD | 4.6% |
| 2021 Q2 | 3.61 Million USD | -74.66% |
| 2021 Q1 | 14.26 Million USD | -24.28% |
| 2021 Q3 | 18.63 Million USD | 415.21% |
| 2021 FY | 35.78 Million USD | 86.09% |
| 2021 Q4 | 35.78 Million USD | 92.1% |
| 2020 Q3 | 18.18 Million USD | -7.68% |
| 2020 FY | 19.23 Million USD | 19.89% |
| 2020 Q4 | 18.84 Million USD | 3.64% |
| 2020 Q1 | 16.46 Million USD | 5.49% |
| 2020 Q2 | 19.69 Million USD | 19.63% |
| 2019 Q4 | 15.6 Million USD | -4.37% |
| 2019 Q3 | 16.31 Million USD | 3.57% |
| 2019 Q2 | 15.75 Million USD | -1.23% |
| 2019 Q1 | 15.95 Million USD | 102.19% |
| 2019 FY | 16.04 Million USD | 90.75% |
| 2018 FY | 8.41 Million USD | -24.28% |
| 2018 Q4 | 7.89 Million USD | -4.73% |
| 2018 Q1 | 11.98 Million USD | 13.52% |
| 2018 Q2 | 10.65 Million USD | -11.1% |
| 2018 Q3 | 8.28 Million USD | -22.3% |
| 2017 FY | 11.1 Million USD | 139.74% |
| 2017 Q1 | 6.19 Million USD | 33.62% |
| 2017 Q3 | 11.05 Million USD | 24.46% |
| 2017 Q4 | 10.56 Million USD | -4.42% |
| 2017 Q2 | 8.87 Million USD | 43.39% |
| 2016 Q4 | 4.63 Million USD | -49.17% |
| 2016 FY | 4.63 Million USD | -18.33% |
| 2016 Q3 | 9.11 Million USD | 110.48% |
| 2016 Q2 | 4.33 Million USD | 287.17% |
| 2016 Q1 | -2.31 Million USD | -137.88% |
| 2015 Q1 | -2.28 Million USD | 72.07% |
| 2015 FY | 5.67 Million USD | 169.25% |
| 2015 Q4 | 6.1 Million USD | 181.99% |
| 2015 Q3 | 2.16 Million USD | 251.36% |
| 2015 Q2 | -1.43 Million USD | 37.46% |
| 2014 Q1 | -14.2 Million USD | 8.85% |
| 2014 Q3 | -10.33 Million USD | 14.5% |
| 2014 Q4 | -8.19 Million USD | 20.76% |
| 2014 Q2 | -12.09 Million USD | 14.85% |
| 2014 FY | -8.19 Million USD | 47.42% |
| 2013 Q3 | -16.82 Million USD | 6.36% |
| 2013 Q4 | -15.57 Million USD | 7.42% |
| 2013 FY | -15.57 Million USD | 0.0% |
| 2013 Q1 | -18.97 Million USD | 0.0% |
| 2013 Q2 | -17.97 Million USD | 5.31% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -655.73 Thousand USD | 16735.963% |
| BIMI International Medical Inc. | 3.11 Million USD | -3397.829% |
| China Jo-Jo Drugstores, Inc. | 10.34 Million USD | -954.41% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 116.41 Million USD | 6.296% |
| Leafly Holdings, Inc. | 13.79 Million USD | -690.944% |
| Leafly Holdings, Inc. | 13.79 Million USD | -690.944% |
| LifeMD, Inc. | -14.21 Million USD | 867.442% |
| LifeMD, Inc. | -14.21 Million USD | 867.442% |
| TRxADE HEALTH, Inc. | 6.95 Million USD | -1469.145% |
| PetMed Express, Inc. | -53.84 Million USD | 302.606% |
| Walgreens Boots Alliance, Inc. | 8.23 Billion USD | 98.675% |